...
首页> 外文期刊>British journal of ophthalmology >Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients
【24h】

Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients

机译:局部复发,转移和皮脂癌的局部复发,转移和存活的预后因素:100名患者的观察结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background/aims To validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis and survival in patients with eyelid sebaceous carcinoma. Methods We performed a retrospective review of 100 consecutive patients with eyelid sebaceous carcinoma. Eyelid carcinomas were staged according to the AJCC 7th-edition and 8th-edition criteria. Associations between T and N categories and disease-related outcomes including local recurrence, lymph node metastasis, distant metastasis and survival were evaluated. Results 60 women and 40 men had a median age of 67 years (range, 41-94 years). The proportions of patients who experienced local recurrence, lymph node metastasis, distant metastasis and death from disease were 6%, 21%, 7% and 6%, respectively. Two-year and 5-year disease-specific survival (DSS) rates were 93.8% and 92.0%, respectively. There were significant correlations between (1) T2c or worse category and lymph node metastasis (p=0.04) and distant metastasis (p=0.01), (2) T3b or worse category and local recurrence (p=0.01) and death from disease (p=0.01) and (3) N1 category at presentation and distant metastasis (p<0.01) and death from disease (p<0.01). The AJCC 8th-edition classification showed a better homogeneity of the T-category distribution (p<0.01) and a slightly higher discrimination ability for lymph node metastasis (C=0.734 vs C=0.728) than the 7th-edition. Conclusions T and N categories per AJCC 8th-edition classification are predictive of local recurrence, metastasis and DSS outcomes for eyelid sebaceous carcinoma. Surgeons should perform strict surveillance testing for nodal and systemic metastases in patients with T2c or worse T category and/or N1 disease at presentation.
机译:背景/旨在验证美国癌症联合委员会(AJCC)8th-Edition患者对眼睑皮脂腺癌患者局部复发,转移和生存的预测价值。方法我们对100名连续患有眼睑皮脂腺癌进行了回顾性审查。根据AJCC第7版和第8版标准进行眼睑癌。评估了T和N类和疾病相关结果的关联,包括局部复发,淋巴结转移,远处转移和生存期。结果60名妇女和40名男子中位年龄为67岁(范围,41-94岁)。经历局部复发,淋巴结转移,远离疾病的患者的比例分别为6%,21%,7%和6%。两年和5年的疾病特异性生存(DSS)率分别为93.8%和92.0%。 (1)T2C或较差的类别和淋巴结转移(P = 0.04)和远处转移(P = 0.01),(2)T3B或更差和局部复发(P = 0.01)和疾病死亡( P = 0.01)和(3)N1类别在介绍和远处转移(P <0.01)和疾病死亡(P <0.01)。 AJCC第8版分类显示T型分布的更好均匀性(P <0.01),淋巴结转移的略微较高的判别能力(C = 0.734 Vs C = 0.728),而不是第7版。结论每个AJCC 8日分类的T和N类是针对眼睑皮脂腺瘤的局部复发,转移和DSS结果的预测性。外科医生应对T2C或较差的T类和/或N1疾病患者进行严格的监测检测对T2C或介绍的较差的T类和/或N1疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号